Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07083076 · ClinicalTrials.gov registry record · NA

Regular Diet Versus Extended Low Residue After Colon Surgery

A NA study of Colon Resection, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
222
Enrollment target
2
Study locations

NCT07083076 is a NA study of Colon Resection that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 222 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07083076, a NA study of Colon Resection, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
222 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to learn if a 10 day low-residue diet restriction is better for bowel function and quality of life without increasing complications compared to a 6 week low-residue diet restriction after elective colon resection surgery. The main questions it aims to answer are: Does a shorter time period of low residue restriction result in a faster return to normal bowel function? Are there any differences in complication rate between a 10 day low-residue diet restriction compared to a 6 week low-residue diet restriction? Participants will be randomized to one of the two diet plans and will be asked to answer surveys about their bowel function and health care related quality of life at various time points for up to 3 months.

Conditions Studied

Interventions

  • OTHER Short term (10 day) low residue diet restriction
  • OTHER 6 week low residue diet restriction

Study Locations (2)

New York

  • North Shore University Hospital - Manhasset
  • Long Island Jewish Hospital - New Hyde Park

Trial Details

FieldValue
Enrollment Target 222 participants
Start Date 2025-09-19
Est. Completion 2028-07-01
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT07083076

The ClinicalTrials.gov registry entry for NCT07083076 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colon Resection appearing as the primary indexed condition, and to 2 interventions - of which Short term (10 day) low residue diet restriction is the first listed.

NCT07083076 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07083076 about?

NCT07083076 is a clinical study titled "Regular Diet Versus Extended Low Residue After Colon Surgery". The goal of this clinical trial is to learn if a 10 day low-residue diet restriction is better for bowel function and quality of life without increasing complications compared to a 6 week low-residue diet restriction after elective colon resection surgery. The main questions it aims to answer are: ...

What is the current status of trial NCT07083076?

This trial is currently recruiting. It is a NA study. The enrollment target is 222 participants. The study started on 2025-09-19. Estimated completion is 2028-07-01.

What conditions does trial NCT07083076 study?

This clinical trial studies the following conditions: Colon Resection.

What interventions are being tested in trial NCT07083076?

The interventions under investigation include: Short term (10 day) low residue diet restriction (OTHER), 6 week low residue diet restriction (OTHER).

Who is sponsoring clinical trial NCT07083076?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07083076 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.